Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Human & Experimental Toxicology|June 8, 2001
Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidoneA P Beelen, K T Yeo, L D Lewis
Sexually Transmitted Diseases|July 30, 2015
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial VaginosisJane R Schwebke, Jeanne Marrazzo, Andrew P Beelen, et al.
Facts, Views & Vision in Obgyn|October 7, 2022
Endometrial polypectomy using tissue removal device or electrosurgical snare: a randomised controlled trialJ van Gemert, M C Herman, P Beelen, et al.
Journal of Clinical Gastroenterology|April 22, 2004
Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal depositionTimothy B Gardner, Harold L Manning, Andrew P Beelen, et al.
JAMA|December 17, 2009
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trialRobert C Green, Lon S Schneider, David A Amato, et al.
Journal of Chemotherapy (Florence, Italy)|October 8, 2013
A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumoursShodeinde A Coker, Uday B Dandamudi, Andrew P Beelen, et al.
Cancer Chemotherapy and Pharmacology|November 4, 2017
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancerKevin M Koch, E Claire Dees, Shodeinde A Coker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Effects of food on the relative bioavailability of lapatinib in cancer patientsKevin M Koch, Nandi J Reddy, Roger B Cohen, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2002
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancerLionel D Lewis, Andrew P Beelen, Bernard F Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Modulation of cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850)Raymond P Perez, Lionel D Lewis, Andrew P Beelen, et al.
Pageof 2